batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Shattuck exits oncology 1 October 2024 IMS 2024 – Darzalex fights back against Sarclisa 27 September 2024 Sanofi sees promise in CD73 26 September 2024 Pfizer’s sickle cell crisis 26 September 2024 Akeso builds up its ivonescimab ambitions again 25 September 2024 Abecma’s first-line hopes dashed 25 September 2024 Merck’s favezelimab is latest Lag3 to falter 25 September 2024 Context could herald what’s next for Nectin-4 24 September 2024 Load More